DRUGS · SERVICE DETAILS

NDC Labeler Code Application, NDC Encoding and Drug Listing

From the point of view of an enterprise’s existing code and the basis for listing the product, separate arrangements are made for Labeler Code requests to be verified, product packaging NDC checks, listing submissions and maintenance, and the company code is not used as a product approval number.

Code allocation, listing acceptance and cataloguing do not represent FDA approval. Listing, real products and labeling information to be verified separately; Individual requests for identification of codes, listings and maintenance scopes.

SERVICE OVERVIEW

What does this service help with?

Align Laborer, physical facilities, labels, products and packaging data, prepare code or list SPL as agreed, follow up feedback and deliver version with record acceptance. Codes are already in place to verify and to avoid unnecessary duplication of applications.

WHO MAY NEED IT

Who should consider this service?

Relevant businesses to be manufacturing or distributing drugs in the United States, requiring application or maintenance codes and listings, including manufacturers and self-owned brand dealers. Responsibilities and submission arrangements should be determined in conjunction with actual activities.

SCOPE & APPROACH

What can the NDC Labeler Code application, NDC code and Drug Listing include?

The enterprises, products and existing records are checked before information responsibilities, delivery content and maintenance are defined.

01

Subject, listing basis and existing code verification

Checking marketing and production relationships, applying listing grounds, companies DUNS and existing codes does not automatically treat each site as a separate subject of code.

02

Labler Code Confirmed after Request and Distribution

Prepare to apply the request SPL, follow up on the FDA allocation and submit updated confirmation records with new codes, as required, to avoid missing confirmation steps.

03

Product and packaging NDC data reconciliation

Distinguishing the current FDA format from other use formats by type of agent, content strength, product and packaging configuration, and avoiding the mixing or copying of non-relevant codes.

04

Label and Listing SPL Preparation

Collapse data on components UNII, formulation type, route of delivery, label graphics and physical facilities, select the appropriate document type and prepare for listing.

05

Sending feedback and public records verification

To submit and process the validation feedback in collaboration with the delegated authority, to preserve the accepted results and to make them publicly available in conjunction with marketing dates, certification status and coverage.

06

Codes, listing updates and annual authentication

Distinguishing code information changes, product listing changes and no change certifications, managing versions and commercial distribution status, and clarifying responsibilities for follow-up maintenance.

GET READY

What to prepare for the assessment

A summary of the project and a catalogue of existing records may be provided first, and detailed documents may be transferred to confidentiality arrangements as authorized.

  • English name, address, DUNS, FDA contacts and existing codes
  • Manufacturing, packaging labelling, brand distribution and import relations
  • Listed route basis, agent type, composition intensity, UNII and route of delivery
  • Current tab text and overpacking and main display image
  • Information on packing specifications, product packaging codes and marketing operations
  • Facilities DUNS, existing SPL and acceptance records
HOW TO START

From initial review to engagement

STEP 01

Check Subject with Existing Data

Identification of codes and listing needs, listing basis, facility relationships and information gaps.

STEP 02

Complete application of code steps

Existing codes are checked first; Follow-up on distribution and confirmation after first request.

STEP 03

Preparation of listings and verification of feedback

Packaging and labelling of products, review of SPL and submission and recording of processing results.

STEP 04

Handover and arrangement update

Delivery version and acceptance of records, verification of public display, agreed change and annual maintenance.

Code allocation, listing acceptance and cataloguing do not represent FDA approval. Listing, real products and labeling information to be verified separately; Individual requests for identification of codes, listings and maintenance scopes.

TIMING & FEES

Timing and fees

Information reviewed:Period of application of costs: reconciliation of official rules: 2026-11-06; The applicable user fees are applied separately from the current fiscal year according to the specific activity.

Timing and preparation

Document preparation

(b) Requesting separate schedules by code with regard to confirmation, product packaging data, label review and listing verification; Main differences, number of items and information gaps affect lead times.

FDA processing

The points at which the initial listing is made and the product changes should be reconciled with the applicable requirements and updated as soon as possible after the change and no later than June or December, as applicable thereafter; The annual unchanged authentication window is from 1 October to 31 December. Codes and listings are not product approval cycles.

Fee breakdown

FDA fees

Registration of general pharmaceutical facilities and submission of Drug Listing does not in and of itself charge a fee; This does not amount to a total FDA obligation for the enterprise to be free of charge. Depending on the actual drug and facility activity, additional user fees are available for GDUFA, OMUFA, PDUFA or other applicable user fees.

Service fees

Request for quotations by code, post-allocation confirmation, quantity of products and packaging, label data collation, submission of feedback and range of maintenance, indicating whether label compliance is included.

Other possible costs

Translation, component identification verification, label drawings, third-party work and applicable user fees are shown separately on a practical basis.

OFFICIAL SOURCES

Official basis of this service

Data check: 2026-11-06. Specific applicability and submission requirements should be identified in conjunction with real business.

START WITH YOUR PRODUCT

Starting with the product and the existing records.

Description of enterprise activities, products and available documentation, identification of information gaps, delivery, processing plans and quotations.